Cleared Special

K223746 - Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange Catheter, ICY Intravascular Heat Exchange Catheter, Quattro Intravascular Heat Exchange Catheter, Thermogard XP Console, Thermogard HQ Console (FDA 510(k) Clearance)

Jan 2023
Decision
30d
Days
Class 2
Risk

K223746 is an FDA 510(k) clearance for the Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange Catheter, ICY Intravascular Heat Exchange Catheter, Quattro Intravascular Heat Exchange Catheter, Thermogard XP Console, Thermogard HQ Console. This device is classified as a System, Hypothermia, Intravenous, Cooling (Class II - Special Controls, product code NCX).

Submitted by Zoll Circulation, Inc. (San Jose, US). The FDA issued a Cleared decision on January 13, 2023, 30 days after receiving the submission on December 14, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 870.5900.

Submission Details

510(k) Number K223746 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received December 14, 2022
Decision Date January 13, 2023
Days to Decision 30 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code NCX - System, Hypothermia, Intravenous, Cooling
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.5900